首页> 外国专利> modified factor viii binding polypeptide, complex, pharmaceutical composition, methods for treating a coagulopathy, to produce a polypeptide comprising a modified vwf, and to increase vwf factor viii binding affinity and factor viii half-life, use of a modified polypeptide or complex, polynucleotide, plasmid or vector, and host cell.

modified factor viii binding polypeptide, complex, pharmaceutical composition, methods for treating a coagulopathy, to produce a polypeptide comprising a modified vwf, and to increase vwf factor viii binding affinity and factor viii half-life, use of a modified polypeptide or complex, polynucleotide, plasmid or vector, and host cell.

机译:修饰的因子VIII结合多肽,复合物,药物组合物,治疗凝血病的方法,产生包含修饰的vwf的多肽并增加vwf因子VII结合亲和力和因子VII的半衰期的方法,修饰的多肽或复合物的用途,多核苷酸,质粒或载体以及宿主细胞。

摘要

The present invention provides a modified polypeptide that binds to factor viii. the modified polypeptide comprises a sequence as defined in sequence: 3 wherein the sequence comprises at least one change in position 1 or 3 such that the modified polypeptide binds to factor viii with a dissociation rate of at least 5 times lower. which is a reference polypeptide comprising an unmodified sequence id: 3.
机译:本发明提供了结合因子vi的修饰的多肽。所述修饰的多肽包含序列3所定义的序列,其中所述序列在位置1或3上包含至少一个改变,使得所述修饰的多肽以至少低5倍的解离速率结合因子VII。它是包含未修饰序列ID的参考多肽:3。

著录项

  • 公开/公告号BR112016030950A2

    专利类型

  • 公开/公告日2018-03-27

    原文格式PDF

  • 申请/专利权人 CSL LIMITED;

    申请/专利号BR20161130950

  • 申请日2015-07-02

  • 分类号C07K14/745;A61K38/36;A61P7/04;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号